Alirocumab
Indication
In Patients with established Cardiovascular Disease - under review
Grey
Brand:
Praluent
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Cardiovascular system
Background
Under review
Recommendation
LSCMMG Recommendation:
Grey
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria
Supporting documents: